Insider · CIK 0001786322

Ciaramella Giuseppe

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001786322

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	BEAMBeam Therapeutics Inc.G Gift	President	GGift	−123K sh	—	—	130,504
2026-06-17	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−29K sh	—	—	56,946
2026-06-17	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+6,505 sh	$0.67	+$4,358.35	224,911
2026-06-17	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+29K sh	$1.03	+$29.9K	253,911
2026-06-17	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−6,505 sh	—	—	0
2026-04-01	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−11.8K sh	$24.58	−$290K	218,406
2026-03-31	BEAMBeam Therapeutics Inc.A Award	President	AAward	+40K sh	—	—	230,216
2026-02-24	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−35K sh	—	—	397,313
2026-02-24	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+35K sh	$17.00	+$595K	225,216
2026-02-24	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−35K sh	$32.00	−$1.12M	190,216
2026-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	President	AAward	+80K sh	—	—	80,000
2025-04-01	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−7,434 sh	$18.35	−$136K	190,216
2025-03-31	BEAMBeam Therapeutics Inc.A Award	President	AAward	+35K sh	—	—	197,650
2025-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	President	AAward	+70K sh	—	—	70,000
2024-12-17	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−53.5K sh	—	—	6,505
2024-12-17	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+53.5K sh	$0.67	+$35.8K	162,650
2024-11-06	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−51.1K sh	$26.36	−$1.35M	109,150
2024-10-14	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−13K sh	—	—	0
2024-10-14	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−1,457 sh	—	—	0
2024-10-14	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−51.1K sh	$26.27	−$1.34M	160,260
2024-10-14	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−27.3K sh	—	—	0
2024-10-14	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+1,457 sh	$7.22	+$10.5K	211,370
2024-10-14	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+27.3K sh	$0.67	+$18.3K	196,934
2024-10-14	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+13K sh	$4.22	+$54.8K	209,913
2024-04-03	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	President	AAward	+13K sh	—	—	12,979
2024-04-03	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	President	AAward	+27.3K sh	—	—	27,318
2024-04-01	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−4,534 sh	$32.12	−$146K	169,616
2024-03-31	BEAMBeam Therapeutics Inc.A Award	President	AAward	+35K sh	—	—	174,150
2024-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	President	AAward	+70K sh	$24.40	+$1.71M	70,000
2023-10-20	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+90.9K sh	$0.67	+$60.9K	139,150
2023-10-20	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−90.9K sh	—	—	60,005
2023-07-24	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+1,206 sh	$7.22	+$8,707.32	49,456
2023-07-24	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−1,206 sh	$32.01	−$38.6K	48,250
2023-07-24	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−1,206 sh	—	—	19,002
2023-07-21	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−155K sh	$32.06	−$4.98M	48,250
2023-07-21	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−69.4K sh	—	—	20,208
2023-07-21	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+69.4K sh	$7.22	+$501K	181,728
2023-07-21	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+21.8K sh	$7.22	+$158K	203,574
2023-07-21	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−21.8K sh	—	—	1,457
2023-04-04	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−1,754 sh	$29.09	−$51K	112,290
2023-04-03	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−1,918 sh	$30.31	−$58.1K	114,044
2023-03-31	BEAMBeam Therapeutics Inc.A Award	President	AAward	+20K sh	—	—	115,962
2023-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	President	AAward	+40K sh	—	—	40,000
2023-01-03	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−13.7K sh	$37.99	−$521K	98,462
2023-01-03	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−40.3K sh	—	—	150,905
2023-01-03	BEAMBeam Therapeutics Inc.S Sale	President	SSale	−37.5K sh	$37.14	−$1.39M	112,166
2023-01-03	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+4,326 sh	$4.22	+$18.3K	109,394
2023-01-03	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−4,326 sh	—	—	0
2023-01-03	BEAMBeam Therapeutics Inc.M Exercise/Conversion	President	MExercise/Conversion	+9,106 sh	$0.67	+$6,101.02	105,068
2023-01-03	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President	MExercise/Conversion	−9,106 sh	—	—	0

Recent filings

Accepted (ET)
Sep 254
Ciaramella Giuseppe0001193125-26-402814
SEC(opens sec.gov)
Jun 224
Ciaramella Giuseppe0001193125-26-277509
SEC(opens sec.gov)
Apr 64
Ciaramella Giuseppe0001193125-26-144054
SEC(opens sec.gov)
Apr 24
Ciaramella Giuseppe0001193125-26-140508
SEC(opens sec.gov)
Feb 264
Ciaramella Giuseppe0001193125-26-076544
SEC(opens sec.gov)
Feb 24
Ciaramella Giuseppe0001193125-26-033606
SEC(opens sec.gov)
Apr 34
Ciaramella Giuseppe0000950170-25-050856
SEC(opens sec.gov)
Apr 24
Ciaramella Giuseppe0000950170-25-049763
SEC(opens sec.gov)
Feb 34
Ciaramella Giuseppe0000950170-25-012306
SEC(opens sec.gov)
Dec 194
Ciaramella Giuseppe0000950170-24-138447
SEC(opens sec.gov)
Nov 84
Ciaramella Giuseppe0000950170-24-124085
SEC(opens sec.gov)
Oct 164
Ciaramella Giuseppe0000950170-24-115031
SEC(opens sec.gov)

Companies

Beam Therapeutics Inc.PresidentBEAM

Address

C/O BEAM THERAPEUTICS INC., 238 MAIN STREET

CAMBRIDGE, MA, 02142